70 - Charlie Webb from Van Der Stahl Scientific

People of Packaging · 19 Aug 2021 · 38m

What this episode covers

Charlie Webb, president of Van Der Stahl Scientific, discusses the rigorous validation and regulatory requirements of medical device packaging, explaining why the process is often more complex than the device development itself. He highlights the critical role of sterile barrier systems in preventing healthcare-associated infections, noting that over 150,000 deaths occur annually in the US due to non-sterile devices. Webb also addresses the challenge of hospitals using inadequate, unvalidated sealing equipment due to budget constraints, advocating for the adoption of microprocessor-controlled systems that ensure reproducibility and reliability.

Other shows on the same ground, closest first.

  • Global Medical Device Podcast · 37m

    Packaging Validation Best Practices

    Jeff Barrett, CEO of J-Pac Medical, explains the complexities of ISO 11607 packaging validation for sterilized medical devices, emphasizing that over a third of validations fail transit testing due to a lack of understanding regarding shipping modes. He details how companies can avoid costly 510(k) delays by conducting feasibility testing, using worst-case scenarios for sterilization, and managing labeling risks, which account for 40% of FDA recalls. Barrett highlights that sterilization validations can cost $40,000-$80,000 and take 16-20 weeks, urging engineers to integrate packaging design early in the process to prevent revalidation issues as companies scale.

  • Being an Engineer · 20m

    S6E51 Eric Richins | What It's Like Being A Packaging Engineer

    Eric Richins, a packaging engineer at Stryker with 10 years of experience, explains the complexities of medical device packaging, distinguishing between primary, secondary, and tertiary layers and the critical role of the Tyvek sterile barrier. He details the regulatory hurdles of sterilization methods like ethylene oxide and gamma radiation, and the massive documentation required for validating automated packaging lines. Richins discusses the challenges of implementing new automation, such as a carton erector that increased throughput from 400 units in three hours to one every six seconds, while managing the gap between design intent and production reality.

  • Global Medical Device Podcast · 37m

    Essentials of Sterilization for Med Device Professionals

    Laura Maher, a Medical Device Guru at Greenlight Guru, explains the technical differences between sterilization modalities like gamma radiation and ethylene oxide (EO), including material compatibility issues with silicone and batteries. She details the validation processes, such as bio-burden testing and dose audits, and highlights emerging FDA-recognized modalities like chlorine dioxide that offer safer in-house options. Maher also discusses critical sterility pitfalls, including packaging failures, water system biofilm management, and the risks of bacterial endotoxins from high initial bioburden.

  • Global Medical Device Podcast · 40m

    How Jon Speer Met His Most Frequent Guest: Mike Drues

    Jon Speer, host of the Global Medical Device Podcast and founder of Greenlight Guru, revisits his 2014 origin story with Mike Drues, president of Vascular Sciences, to discuss their past debates on medical device design controls. They analyze the tension between following the literal letter of FDA regulations versus understanding their intent, arguing that many companies fail because they treat compliance as a checkbox exercise rather than a rigorous engineering process. The conversation highlights the danger of assuming users know their own needs, which stifles revolutionary product development in favor of evolutionary improvements, and emphasizes the critical importance of validating validation methods and addressing off-label use in risk management.

  • Global Medical Device Podcast · 25m

    Should design controls have prevented the recent reprocessing tragedy: Do we need new regulation?

    Moderator Bill Loss hosts Mike Drues of Vascular Sciences, Jon Speer of Greenlight Guru, and Jason McKibbin to discuss whether design controls could have prevented the superbug outbreak linked to improperly reprocessed duodenoscopes. The panel argues that manufacturers must adopt 'design for reprocessability' by considering the hospital reprocessing environment during the design phase, rather than ignoring unintended reuse. They contend that existing FDA regulations and ISO 14971 risk management standards are sufficient if followed rigorously, emphasizing that better communication between OEMs and hospitals is the critical missing link.

The summary, chapters and topics are generated from the episode’s audio by this directory, not written by People of Packaging. The episode itself belongs to its publisher.